Hikma Pharmaceuticals PDMR Bassam Kanaan sells £1.05m of shares, further £82,500 the next day
A filing on the FCA's National Storage Mechanism shows Bassam Kanaan disposed of 61,941 Hikma Pharmaceuticals shares at £16.92 each on 5 November 2026, followed by a further 5,000 shares at £16.50 on 6 November.
Written and published automatically by the Loro Intelligence Engine from public records. No editor reviewed this before publication.
An FCA National Storage Mechanism filing dated 9 November 2026 shows Hikma Pharmaceuticals PDMR Bassam Kanaan sold 61,941 shares at £16.92 on 5 November 2026 for £1,048,041.72, followed by a further 5,000 shares at £16.50 on 6 November 2026 for £82,500, both on the London Stock Exchange.
- Person
- Bassam Kanaan (PDMR)
- First disposal
- 61,941 shares at £16.92 on 5 November 2026, totalling £1,048,041.72
- Second disposal
- 5,000 shares at £16.50 on 6 November 2026, totalling £82,500
- Instrument
- Ordinary shares of 10 pence each (ID GB00B0LCW083)
- Venue
- London Stock Exchange (XLON)
Hikma Pharmaceuticals PLC disclosed on 9 November 2026 that a person discharging managerial responsibilities, Bassam Kanaan, sold shares in the company on two consecutive days. The filing states that on 5 November 2026 Kanaan disposed of 61,941 ordinary shares of 10 pence each at a price of £16.92 per share, for a total of £1,048,041.72. The transaction took place on the London Stock Exchange.
The same filing records a second disposal the following day, 6 November 2026, of 5,000 shares at £16.50 each, totalling £82,500, also on the London Stock Exchange.
The filing describes Kanaan's position only as "PDMR" and does not state his specific role at Hikma or give a reason for the disposals. It also does not disclose Kanaan's remaining shareholding in the company after the sales.
Primary sources
1 recordEvery factual claim above is drawn from these records. Each link resolves to the publisher’s own copy.